-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMUNEERING CORP - TO DOSE FIRST PATIENT IN PHASE 3 TRIAL MID-2026

Reuters·01/07/2026 21:00:00

Please log in to view news